Home › Funds › Artia Global Partners LP › TVTX
Artia Global Partners LP position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Artia Global Partners LP reported holding 398,493 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$23.5M, representing 4.73% of its reported portfolio and ranking #7 among its reported holdings. Artia Global Partners LP has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's TVTX position evolved
Artia Global Partners LP first disclosed a stake in TVTX in Q1 2025 at 30,900 shares (US$554K). The position peaked in Q3 2026 at 398,493 shares, worth US$23.5M. Across 7 filings, Artia Global Partners LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 398,493 shares valued at US$23.5M — an increase of 59,460 shares quarter over quarter.. Notable position changes include a 129% increase in Q4 2025 (shares fell 22% over the following quarter), a 380% increase in Q2 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 30.90K | $553.73K | New |
| Q2 2025 | 30.90K | $457.32K | Hold |
| Q3 2025 | 30.90K | $738.51K | Hold |
| Q4 2025 | 70.70K | $2.70M | Add |
| Q1 2026 | 70.70K | $2.10M | Hold |
| Q2 2026 | 339.03K | $19.26M | Add |
| Q3 2026 | 398.49K | $23.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$129.8M), Kynam Capital Management, LP (US$117.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.20M sh · $129.78M · Q3 2026
- Kynam Capital Management, LP 2.00M sh · $117.76M · Q3 2026
- Stephens Investment Management Group LLC 1.88M sh · $110.50M · Q3 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $90.27M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Jones Hill Capital LP 959.63K sh · $56.50M · Q3 2026
- ARMISTICE CAPITAL, LLC 720.00K sh · $42.39M · Q3 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held TVTX?
Artia Global Partners LP has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in TVTX?
As of Q3 2026, Artia Global Partners LP holds 398.49K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $23.46M, representing 4.73% of its reported portfolio and ranking #7.
Has Artia Global Partners LP been buying or selling TVTX?
In the latest 13F filing (Q3 2026), Artia Global Partners LP increased its position in TVTX. The position peaked in Q3 2026 at 398.49K shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.